These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 15228190)

  • 1. Antibodies against cyclic citrullinated peptide (CCP) and levels of cartilage oligomeric matrix protein (COMP) in very early arthritis: relation to diagnosis and disease activity.
    Söderlin MK; Kastbom A; Kautiainen H; Leirisalo-Repo M; Strandberg G; Skogh T
    Scand J Rheumatol; 2004; 33(3):185-8. PubMed ID: 15228190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cartilage oligomeric matrix protein associates differentially with erosions and synovitis and has a different temporal course in cyclic citrullinated peptide antibody (anti-CCP)-positive versus anti-CCP-negative early rheumatoid arthritis.
    Christensen AF; Lindegaard H; Hørslev-Petersen K; Hetland ML; Ejbjerg B; Stengaard-Pedersen K; Jacobsen S; Lottenburger T; Ellingsen T; Andersen LS; Hansen I; Skjødt H; Pedersen JK; Lauridsen UB; Svendsen A; Tarp U; Pødenphant J; Østergaard M; Junker P
    J Rheumatol; 2011 Aug; 38(8):1563-8. PubMed ID: 21572145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early diagnostic and prognostic values of anti-cyclic citrullinated peptide antibody and cartilage oligomeric matrix protein in rheumatoid arthritis.
    Algergawy SA; Abd El-Sabour M; Osman AS; Emam SM; Elham N
    Egypt J Immunol; 2013; 20(2):11-20. PubMed ID: 24617043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measurement of biomarkers in juvenile idiopathic arthritis patients and their significant association with disease severity: a comparative study.
    Gilliam BE; Chauhan AK; Low JM; Moore TL
    Clin Exp Rheumatol; 2008; 26(3):492-7. PubMed ID: 18578976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low serum level of COMP, a cartilage turnover marker, predicts rapid and high ACR70 response to adalimumab therapy in rheumatoid arthritis.
    Morozzi G; Fabbroni M; Bellisai F; Cucini S; Simpatico A; Galeazzi M
    Clin Rheumatol; 2007 Aug; 26(8):1335-8. PubMed ID: 17285224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decrement of serum cartilage oligomeric matrix protein (COMP) in rheumatoid arthritis (RA) patients achieving remission after 6 months of etanercept treatment: comparison with CRP, IgM-RF, MMP-3 and anti-CCP Ab.
    Kawashiri SY; Kawakami A; Ueki Y; Imazato T; Iwamoto N; Fujikawa K; Aramaki T; Tamai M; Nakamura H; Origuchi T; Ida H; Eguchi K
    Joint Bone Spine; 2010 Oct; 77(5):418-20. PubMed ID: 20864374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic impact of contemporary biomarker assays for rheumatoid arthritis.
    Nikolaisen C; Rekvig OP; Nossent HC
    Scand J Rheumatol; 2007; 36(2):97-100. PubMed ID: 17476614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic laboratory markers of joint damage in rheumatoid arthritis.
    Lindqvist E; Eberhardt K; Bendtzen K; Heinegård D; Saxne T
    Ann Rheum Dis; 2005 Feb; 64(2):196-201. PubMed ID: 15458956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison between IgG- and IgA-class antibodies to cyclic citrullinated peptides and to modified citrullinated vimentin in early rheumatoid arthritis and very early arthritis.
    Svärd A; Kastbom A; Söderlin MK; Reckner-Olsson Å; Skogh T
    J Rheumatol; 2011 Jul; 38(7):1265-72. PubMed ID: 21459947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High serum cartilage oligomeric matrix protein determines the subset of patients with early-stage rheumatoid arthritis with high serum C-reactive protein, matrix metalloproteinase-3, and MRI-proven bone erosion.
    Fujikawa K; Kawakami A; Tamai M; Uetani M; Takao S; Arima K; Iwamoto N; Aramaki T; Kawashiri S; Ichinose K; Kamachi M; Nakamura H; Origuchi T; Ida H; Aoyagi K; Eguchi K
    J Rheumatol; 2009 Jun; 36(6):1126-9. PubMed ID: 19447929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-cyclic citrullinated peptide antibodies and IL-23p19 in psoriatic arthritis.
    Shibata S; Tada Y; Komine M; Hattori N; Osame S; Kanda N; Watanabe S; Saeki H; Tamaki K
    J Dermatol Sci; 2009 Jan; 53(1):34-9. PubMed ID: 18752933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of Serum cartilage oligomeric matrix protein (COMP) in the diagnosis of rheumatoid arthritis (RA): A case-control study.
    Liu F; Wang X; Zhang X; Ren C; Xin J
    J Int Med Res; 2016 Aug; 44(4):940-9. PubMed ID: 27217240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating secretory IgA antibodies against cyclic citrullinated peptides in early rheumatoid arthritis associate with inflammatory activity and smoking.
    Roos K; Martinsson K; Ziegelasch M; Sommarin Y; Svärd A; Skogh T; Kastbom A
    Arthritis Res Ther; 2016 May; 18(1):119. PubMed ID: 27215344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum levels of cartilage oligomeric matrix protein. A predicting factor and a valuable parameter for disease management in rheumatoid arthritis.
    Skoumal M; Kolarz G; Klingler A
    Scand J Rheumatol; 2003; 32(3):156-61. PubMed ID: 12892252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic utility of anti-cyclic citrullinated peptide antibodies for very early rheumatoid arthritis.
    Matsui T; Shimada K; Ozawa N; Hayakawa H; Hagiwara F; Nakayama H; Sugii S; Ozawa Y; Tohma S
    J Rheumatol; 2006 Dec; 33(12):2390-7. PubMed ID: 16924694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibodies to citrullinated proteins and differences in clinical progression of rheumatoid arthritis.
    van der Helm-van Mil AH; Verpoort KN; Breedveld FC; Toes RE; Huizinga TW
    Arthritis Res Ther; 2005; 7(5):R949-58. PubMed ID: 16207336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic utility of anti-cyclic citrullinated peptide and anti-modified citrullinated vimentin antibodies in rheumatoid arthritis.
    Keskin G; Inal A; Keskin D; Pekel A; Baysal O; Dizer U; Sengül A
    Protein Pept Lett; 2008; 15(3):314-7. PubMed ID: 18336364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The role of anti-cyclic citrullinated peptide (anti-CCP) antibodies in serologic diagnosis and evaluation of disease activity in rheumatoid arthritis].
    Aridoğan BC; Kaya S; Savaş S; Cetin ES; Akkuş S; Demirci M
    Mikrobiyol Bul; 2008 Oct; 42(4):669-74. PubMed ID: 19149089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum cartilage oligomeric matrix protein (COMP) in rheumatoid arthritis and knee osteoarthritis.
    Wisłowska M; Jabłońska B
    Clin Rheumatol; 2005 Jun; 24(3):278-84. PubMed ID: 15940561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-CCP antibodies measured at disease onset help identify seronegative rheumatoid arthritis and predict radiological and functional outcome.
    Quinn MA; Gough AK; Green MJ; Devlin J; Hensor EM; Greenstein A; Fraser A; Emery P
    Rheumatology (Oxford); 2006 Apr; 45(4):478-80. PubMed ID: 16287917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.